Weight Management
Weight Management
Embedded Files
Protocols
Protocols
Summary Charts & Documents
Summary Charts & Documents
Comparison of Weight Loss Products 1_2025Weight Loss Products
January 2025
Nutrition Guidelines for Wt Loss.PCM.Urgent.Nov2024 (1).pdfNutrition Guidelines for Weight Loss
Last Reviewed 11/7/24
We Go Together Program InformationWe Go Together Program Information
Updated November 2024
Bariatric Surgery and Medication UseBariatric Surgery and Medication Use
Updated June 2024
segment-340310-pdf (1).pdfBariatric Surgery and Medication Use
March 2018
Health Educator’s Nutrition Toolkit Setting the Table for Healthy Eating.pdf.pdfHealth Educator's Nutrition Toolkit
Presentations
Presentations
Obesity CE- Slides.pdfWeighing In On Glucagon-Like Peptide 1 Receptor Agonists for Obesity Management.pdfWeighing In On Glucagon-Like Peptide 1 Receptor Agonists for Obesity Management
Weighing In On Glucagon-Like Peptide 1 Receptor Agonists for Obesity Management
Date: October 28, 2021
Speaker(s):
Michael Maiullari, PharmD
PGY1 Pharmacy Resident - Cambridge Health Alliance
Learning Objectives:
Describe the epidemiology of obesity and its relationship to the pathophysiology and development of type 2 diabetes mellitus (T2DM)
Compare the mechanisms of action for weight loss, therapeutic effectiveness, and side effect profiles of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and obesity management medications
Interpret clinical findings from primary literature to compare therapeutic effects of GLP-1 RAs and obesity management medications
Design a therapeutic weight loss regimen using patient-specific factors for a given case
Bariatric_Surgery_PPT_Slides.pdfBariatric_Surgery_Supplemental_Resource.pdfBeyond Bariatric Surgery: Navigating Medication and Metabolic Changes
Beyond Bariatric Surgery: Navigating Medication and Metabolic Changes
Date: January 26, 2024
Speaker(s):
Jack Mountain, PharmD
PGY1 Pharmacy Resident - Cambridge Health Alliance
Learning Objectives:
Compare pharmacokinetic changes in patients following malabsorptive and restrictive bariatric procedures to those without bypass surgery.
Identify strategies to mitigate anticipated pharmacokinetic and metabolic changes status-post gastric bypass.
Given a patient case, apply expert opinion and evidence based recommendations for the treatment of nutritional status, hypertension, and diabetes following gastric bypass.
Page updated
Report abuse